Justin S. Cisar

1.1k total citations
15 papers, 643 citations indexed

About

Justin S. Cisar is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Justin S. Cisar has authored 15 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Organic Chemistry. Recurrent topics in Justin S. Cisar's work include Biochemical and Molecular Research (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and HIV/AIDS drug development and treatment (3 papers). Justin S. Cisar is often cited by papers focused on Biochemical and Molecular Research (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and HIV/AIDS drug development and treatment (3 papers). Justin S. Cisar collaborates with scholars based in United States, Belgium and Puerto Rico. Justin S. Cisar's co-authors include Benjamin F. Cravatt, Derek S. Tan, Jie Song, Carolyn R. Bertozzi, Jing Li, Abimael D. Rodrı́guez, Daniel Romo, Howard J. Williams, Luis E. N. Quadri and Shaun K. Olsen and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and PLoS ONE.

In The Last Decade

Justin S. Cisar

15 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin S. Cisar United States 11 321 298 125 61 55 15 643
Brigitta Elsässer Germany 16 321 1.0× 188 0.6× 177 1.4× 61 1.0× 33 0.6× 28 690
Fumika Yakushiji Japan 19 440 1.4× 401 1.3× 139 1.1× 46 0.8× 30 0.5× 52 830
Isabelle Correia France 15 680 2.1× 147 0.5× 85 0.7× 60 1.0× 66 1.2× 34 921
Sahar Ahmed Egypt 17 334 1.0× 321 1.1× 44 0.4× 84 1.4× 94 1.7× 30 683
Luca Gambini United States 15 341 1.1× 217 0.7× 40 0.3× 134 2.2× 21 0.4× 22 613
Subhasish Tapadar United States 16 469 1.5× 300 1.0× 60 0.5× 120 2.0× 11 0.2× 25 689
Scott Lew United States 15 676 2.1× 101 0.3× 39 0.3× 49 0.8× 49 0.9× 19 827
Yosup Rew United States 17 500 1.6× 237 0.8× 150 1.2× 116 1.9× 11 0.2× 26 779
Sunil Singh India 9 337 1.0× 182 0.6× 48 0.4× 38 0.6× 34 0.6× 20 442
Christina Smith United States 15 430 1.3× 199 0.7× 82 0.7× 37 0.6× 21 0.4× 17 757

Countries citing papers authored by Justin S. Cisar

Since Specialization
Citations

This map shows the geographic impact of Justin S. Cisar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin S. Cisar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin S. Cisar more than expected).

Fields of papers citing papers by Justin S. Cisar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin S. Cisar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin S. Cisar. The network helps show where Justin S. Cisar may publish in the future.

Co-authorship network of co-authors of Justin S. Cisar

This figure shows the co-authorship network connecting the top 25 collaborators of Justin S. Cisar. A scholar is included among the top collaborators of Justin S. Cisar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin S. Cisar. Justin S. Cisar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rompaey, Dries Van, Mazen Ahmad, Justin S. Cisar, et al.. (2024). Toward Dose Prediction at Point of Design. Journal of Medicinal Chemistry. 67(24). 22282–22290. 5 indexed citations
2.
Zhang, Zhuming, Justin S. Cisar, Xiaochun Zhang, et al.. (2024). Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML. Journal of Medicinal Chemistry. 67(13). 11254–11272. 2 indexed citations
3.
Pietsch, E. Christine, Justin S. Cisar, Edgar Jacoby, et al.. (2024). Discovery of Alternative Binding Poses through Fragment-Based Identification of DHODH Inhibitors. ACS Medicinal Chemistry Letters. 15(3). 381–387. 1 indexed citations
4.
Cisar, Justin S., Edgar Jacoby, Faraz Kazmi, et al.. (2022). N-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia. Journal of Medicinal Chemistry. 65(16). 11241–11256. 12 indexed citations
5.
Reardon, Holly T., Cassandra L. Henry, Nhi Ngo, et al.. (2019). Quantification of In Vivo Target Engagement Using Microfluidic Activity-Based Protein Profiling. SLAS TECHNOLOGY. 24(5). 489–498. 4 indexed citations
6.
Cisar, Justin S., Jason R. Clapper, Jacqueline L. Blankman, et al.. (2018). Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders. Journal of Medicinal Chemistry. 61(20). 9062–9084. 97 indexed citations
7.
Li, Jing, Justin S. Cisar, Howard J. Williams, et al.. (2013). Simultaneous structure–activity studies and arming of natural products by C–H amination reveal cellular targets of eupalmerin acetate. Nature Chemistry. 5(6). 510–517. 108 indexed citations
8.
Lun, Shichun, Haidan Guo, John Adamson, et al.. (2013). Pharmacokinetic and In Vivo Efficacy Studies of the Mycobactin Biosynthesis Inhibitor Salicyl-AMS in Mice. Antimicrobial Agents and Chemotherapy. 57(10). 5138–5140. 43 indexed citations
9.
Cisar, Justin S., et al.. (2012). Activity-Based Labeling of Matrix Metalloproteinases in Living Vertebrate Embryos. PLoS ONE. 7(8). e43434–e43434. 15 indexed citations
10.
Cisar, Justin S. & Benjamin F. Cravatt. (2012). Fully Functionalized Small-Molecule Probes for Integrated Phenotypic Screening and Target Identification. Journal of the American Chemical Society. 134(25). 10385–10388. 85 indexed citations
11.
Long, Jonathan Z., Justin S. Cisar, Sherry Niessen, et al.. (2011). Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipids. Nature Chemical Biology. 7(11). 763–765. 53 indexed citations
12.
Lu, Xuequan, Shaun K. Olsen, Allan D. Capili, et al.. (2010). Designed Semisynthetic Protein Inhibitors of Ub/Ubl E1 Activating Enzymes. Journal of the American Chemical Society. 132(6). 1748–1749. 67 indexed citations
13.
Cisar, Justin S. & Derek S. Tan. (2008). Small molecule inhibition of microbial natural product biosynthesis—an emerging antibiotic strategy. Chemical Society Reviews. 37(7). 1320–1320. 23 indexed citations
14.
Cisar, Justin S., Julián A. Ferreras, Rajesh Soni, Luis E. N. Quadri, & Derek S. Tan. (2007). Exploiting Ligand Conformation in Selective Inhibition of Non-Ribosomal Peptide Synthetase Amino Acid Adenylation with Designed Macrocyclic Small Molecules. Journal of the American Chemical Society. 129(25). 7752–7753. 37 indexed citations
15.
Song, Jie, Justin S. Cisar, & Carolyn R. Bertozzi. (2004). Functional Self-Assembling Bolaamphiphilic Polydiacetylenes as Colorimetric Sensor Scaffolds. Journal of the American Chemical Society. 126(27). 8459–8465. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026